Online citations, reference lists, and bibliographies.
← Back to Search

Enalaprilat And Enalapril Maleate Eyedrops Lower Intraocular Pressure In Rabbits

T. Loftsson, Sigridur Thorisdóttir, H. Fridriksdóttir, E. Stefánsson
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose:  This study aimed to develop low‐viscosity aqueous eyedrops containing enalaprilat and its prodrug enalapril maleate in solution, and to evaluate the eyedrops in rabbits.
This paper references
10.1111/j.1365-2362.2005.01544.x
Diabetic nephropathy and anaemia
E. Ritz (2005)
10.1016/S0169-409X(98)00055-6
Cyclodextrins in ophthalmic drug delivery.
Loftssona (1999)
Nerve conduction velocity and evoked potential latencies in strep - tozotocin - diabetic rats : effects of treatment with an angiotensin - converting enzyme inhibitor
SM Manschot (2003)
10.1016/S0953-6205(99)00068-0
Effect of enalapril on the incidence of retinopathy in normotensive patients with type 2 diabetes
R. Rachmani (2000)
10.1016/S0140-6736(07)61304-X
Vascular outcome in type 2 diabetes: an ADVANCE?
N. Kaplan (2007)
10.7326/0003-4819-87-5-646_4
Handbook on Injectable Drugs
L. Trissel (1983)
10.1034/J.1600-0420.2002.800205.X
Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.
T. Loftsson (2002)
10.1691/PH.2008.7322
Topical drug delivery to the posterior segment of the eye: anatomical and physiological considerations.
T. Loftsson (2008)
10.1111/J.1600-0420.2007.00885.X
Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
H. Sigurdsson (2007)
Appendix II . Design and optimization of dosage regiments : pharmacokinetic data
KE Tummel (2001)
Enalapril maleate
DP Ip (1987)
Enalapril and diltiazem co-administration and respiratory side effects of enalapril.
S. Fraňová (2005)
10.1089/JOP.1990.6.1
Prostaglandins mediate the ocular hypotensive action of the angiotensin converting enzyme inhibitor MK-422 (enalaprilat) in African green monkeys.
V. Lotti (1990)
10.1002/dmrr.401
Nerve conduction velocity and evoked potential latencies in streptozotocin‐diabetic rats: effects of treatment with an angiotensin converting enzyme inhibitor
S. Manschot (2003)
Nerve conduction velocity and evoked potential latencies in streptozotocin-diabetic rats: effects of treatment with an angiotensin-converting enzyme
SM Manschot (2003)
10.1016/J.ADDR.2007.05.012
Cyclodextrins as pharmaceutical solubilizers.
M. Brewster (2007)
10.1016/S1773-2247(07)50001-8
Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug
T. Loftsson (2007)
10.1089/JOP.1987.3.295
Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits.
R. W. Watkins (1987)
Angiotensin-converting enzyme inhibitors, antagonists and calcium blockers
M Harrold (2007)
10.1002/JPS.20992
Effects of cyclodextrins on drug delivery through biological membranes.
T. Loftsson (2007)
10.7326/0003-4819-94-6-826_2
Applied biopharmaceutics and pharmacokinetics
L. Shargel (1980)
10.1016/J.JPBA.2007.09.014
Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
S. Bhardwaj (2008)
Clarke's analysis of drugs and poisons
A. Moffat (2003)



This paper is referenced by
10.1080/14728222.2018.1486822
Trabecular meshwork ECM remodeling in glaucoma: could RAS be a target?
Puneet Agarwal (2018)
10.1080/07853890.2020.1758341
Local ocular renin–angiotensin–aldosterone system: any connection with intraocular pressure? A comprehensive review
Mervi Holappa (2020)
10.1016/j.ejps.2017.12.015
Intraocular pressure lowering effect and structure‐activity relationship of imidazo[1,2‐a]benzimidazole and pyrimido[1,2‐a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity
A. J. Marcus (2018)
10.1371/journal.pone.0133149
Ocular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in Rats
G. Foureaux (2015)
10.1517/13543784.2011.579901
Medical treatment of glaucoma: present and future
P. Fogagnolo (2011)
10.1111/j.2042-7158.2011.01279.x
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes
T. Loftsson (2011)
10.1016/j.ijpharm.2017.04.010
Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye.
T. Loftsson (2017)
10.4155/fsoa-2016-0071
LC–MS/MS assay for quantitation of enalapril and enalaprilat in plasma for bioequivalence study in Indian subjects
D. Halder (2017)
10.3109/10837450.2014.910811
Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops
P. Jansook (2015)
10.1039/c7em00099e
Baseline toxicity and ion-trapping models to describe the pH-dependence of bacterial toxicity of pharmaceuticals.
Andreas Baumer (2017)
10.1167/tvst.9.12.6
A Novel Topical Ophthalmic Formulation to Mitigate Acute Mustard Gas Keratopathy In Vivo: A Pilot Study
R. Tripathi (2020)
10.1016/j.ejphar.2014.02.021
Mechanisms of angiotensin converting enzyme inhibitor-induced IOP reduction in normotensive rats.
R. Agarwal (2014)
10.1016/j.exer.2011.11.019
Effect of SPP 635, a renin inhibitor, on intraocular pressure in glaucomatous monkey eyes.
Rongfang Wang (2012)
Semantic Scholar Logo Some data provided by SemanticScholar